Sterile medical packaging services in Singapore

Sterile medical packaging is the sterile barrier system — the Tyvek pouch, thermoform tray or blister that keeps a device sterile from the production line to the point of use — and in Singapore it is a genuinely thin, engineering-led capability rather than a crowded converter market. A device maker sourcing here works through a fixed evaluation stack: ISO 11607 validation of the sterile barrier (seal strength, integrity, accelerated ageing), ISO 13485 quality management, cleanroom class for packaging and sealing (typically ISO Class 7 or better), and — critically — where the finished product will actually be sterilised. Because the packaging and the sterilisation method are validated together, the buyer's real question is not just "who can make a Tyvek pouch" but "who can design a barrier system that survives my sterilisation cycle, and where does that cycle run." Very few names in Singapore answer the whole stack; most answer one slice of it.

The shape of the local set is small and specialised. Actual manufacturing is limited: Amcor runs a healthcare film and cleanroom plant at Tuas, and SUPERPAK is a home-grown converter making thermoform trays and Tyvek/medical-paper pouches to ISO 11607. Two global sterile-barrier specialists — Oliver Healthcare Packaging and Nelipak — hold Singapore as Asia-Pacific technical/development centres that design, prototype and validate barrier systems rather than mass-produce them, meaning much finished-format volume is still tooled or run offshore. On sterilisation, STERIS (STERIS Tomoe) at Jalan Buroh is the single significant ethylene-oxide (EtO) contract facility on the island; there is no local gamma or e-beam capacity, so any device requiring those methods ships to Thailand or Malaysia — a real logistics tax the buyer must plan around. The honest read: perhaps two physical packaging manufacturers, two design/validation centres, and one EtO sterilisation plant. Beyond that, the "sterile packaging Singapore" web results are dominated by generic converters and Malaysia-based suppliers marketing across the Causeway — not local sterile-barrier capability.